Anti-RUNX2 抗体 [EPR14334]
Anti-RUNX2 antibody [EPR14334]
- Recombinant
- Advanced Validation
- RabMAb
- 20ul selling size
- 詳細を見る
5
(8 Reviews)
|
(190 Publications)
Anti-RUNX2 antibody [EPR14334] (ab192256) is a rabbit monoclonal antibody detecting RUNX2 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- Biophysical QC for unrivalled batch-batch consistency
- Over 110 publications
別名を表示する
AML3, CBFA1, OSF2, PEBP2A, RUNX2, Runt-related transcription factor 2, Acute myeloid leukemia 3 protein, Core-binding factor subunit alpha-1, Oncogene AML-3, Osteoblast-specific transcription factor 2, Polyomavirus enhancer-binding protein 2 alpha A subunit, SL3-3 enhancer factor 1 alpha A subunit, SL3/AKV core-binding factor alpha A subunit, CBF-alpha-1, OSF-2, PEA2-alpha A, PEBP2-alpha A
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX2 antibody [EPR14334] (AB192256)
Immunohistochemical analysis of paraffin-embedded Human osteosarcoma tissue labeling RUNX2 with ab192256 at 1/1000 dilution. A ready to use HRP Polymer for Rabbit IgG was used as the secondary. Hematoxylin counterstain.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-RUNX2 antibody [EPR14334] (AB192256)
Immunofluorescent analysis of 4% formaldehyde fixed PC3 cells labeling RUNX2 using ab192256 at a 1/500 dilution. A Goat anti rabbit IgG (Alexa Fluor®488) ab150077 was used as the secondary at a 1/200 dilution. Counterstain DAPI. Permeabilized using 0.1% Triton X-100. The two negative controls : 1. Primary ab concentration (anti-RUNX2) is 1 : 500 dilution, Secondary ab (Goat anti mouse IgG (Alexa Fluor®594)) is 1 : 500 dilution; 2. Primary ab concentration (anti-RUNX2) is 1 : 500 dilution, Secondary ab (Goat anti mouse IgG (Alexa Fluor®594)) is 1 : 500 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX2 antibody [EPR14334] (AB192256)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling RUNX2 with ab192256 at 1/1000 dilution. A ready to use HRP Polymer for Rabbit IgG was used as the secondary. Hematoxylin counterstain.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-RUNX2 antibody [EPR14334] (AB192256)
ab192256 staining RUNX2 in PC-3 (human prostate adenocarcinoma) by intracellular flow cytometry. Cells were fixed with 4% paraformaldehyde, permabilised with 90% methanol and the sample was incubated with the primary antibody at a dilution of 1/50. A goat anti rabbit IgG (Alexa Fluorr® 488) at a dilution of 1/2000 was used as the secondary antibody.
Isoytype control : Rabbit monoclonal IgG (Black)
Unlabelled control : Cell without incubation with primary antibody and secondary antibody (Blue)
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-RUNX2 antibody [EPR14334] (AB192256)
Immunocytochemistry/Immunofluorescence analysis of Saos-2 (Human osteosarcoma cell line) labeling RUNX2 with purified ab192256 at 1/1000 dilution. Cells were fixed with 4% PFA and permeabilized with 0.1% tritonX-100. ab150077 Goat anti rabbit IgG (Alexa Fluor®488) at 1/1000 was used as the secondary antibody. Nuclei were counterstained with DAPI. PBS was used instead of the primary antibody as the negative control.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX2 antibody [EPR14334] (AB192256)
Immunohistochemical analysis of paraffin-embedded Mouse spleen tissue labeling RUNX2 with ab192256 at 1/1000 dilution. A ready to use HRP Polymer for Rabbit IgG was used as the secondary. Hematoxylin counterstain.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-RUNX2 antibody [EPR14334] (AB192256)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
ab181602 was used as a GAPDH loading control
Below the target band, there are multi bands may be caused by protein degradation. We suggest customer to use freshly lysate to minimize protein degradation in western blot.
Low express : MCF-7 (PMID : 32509221, 16166639, 20591170)
All lanes:
Western blot - Anti-RUNX2 antibody [EPR14334] (ab192256) at 1/1000 dilution
Lane 1:
PC-3 (human prostate adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
MDA-MB-231 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 4:
MEF (mouse embryonic fibroblast (immortalized)), whole cell lysate at 20 µg
Lane 5:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 6:
C2C12 (Mouse myoblasts myoblast) whole cell lysate at 20 µg
Lane 7:
C6 (rat glial tumor glial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 60 kDa
false
Exposure time: 10s
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-RUNX2 antibody [EPR14334] (AB192256)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 105 Saos-2 cells and 5 µg of ab192256 [EPR14334]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-RUNX2 antibody [EPR14334] (AB192256)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 105 Saos-2 cells and 5 µg of ab192256 [EPR14334]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-RUNX2 antibody [EPR14334] (AB192256)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 105 Saos-2 cells and 5 µg of ab192256 [EPR14334]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Lab
Western blot - Anti-RUNX2 antibody [EPR14334] (AB192256)
Western blot : Anti-RUNX2 antibody [EPR14334] (ab192256) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab192256 was shown to bind specifically to RUNX2. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
All lanes:
Western blot - Anti-RUNX2 antibody [EPR14334] (ab192256)
Lane 1:
Saos-2 cell lysate
Lane 2:
MC3T3-E1 undifferentiated cell lysate
Lane 3:
MC3T3-E1 7-day Osteogenic differentiation cell lysate
Lane 4:
MC3T3-E1 14-day Osteogenic differentiation cell lysate
Lane 5:
MC3T3-E1 28-day Osteogenic differentiation cell lysate
Lane 6:
C2C12 cell lysate
Lane 7:
SH-SY5Y cell lysate
Lane 8:
NIH/3T3 cell lysate
Lane 9:
LNCaP cell lysate
false
関連する標識済み抗体及び組成の異なる製品 (3)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-RUNX2 antibody [EPR14334]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-RUNX2 antibody [EPR14334]
-
Anti-RUNX2 antibody [EPR14334] - BSA and Azide free
Reactivity data
製品の詳細
Product Specifications
Anti-RUNX2 antibody [EPR14334] (ab192256) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ChIC/CUT&RUN-seq, Flow Cyt (Intra), ICC/IF, IHC-P and WB in human, mouse and rat samples.
Anti-RUNX2 antibody [EPR14334] (ab192256) specifically detects RUNX2 (UniProt ID: Q13950; Molecular weight: 57kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-RUNX2 antibody [EPR14334] (ab192256) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-RUNX2 antibody [EPR14334] (ab192256) has been cited over 114 times in peer reviewed journals and is trusted by the scientific community.
Anti-RUNX2 antibody [EPR14334] (ab192256) has 8 independent reviews from customers.
Related Products
Antibody clone EPR14334 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647 (ab215954, ab215955).
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein orchestrates bone formation by influencing the expression of genes involved in osteoblast differentiation. RUNX2 operates as part of the larger transcriptional complex that includes other proteins that modulate its activity. It maintains bone homeostasis by regulating the expression of osteogenic markers including bone sialoprotein and osteocalcin. The ability of RUNX2 to drive osteoblast lineage commitment highlights its importance in skeletal health and development.
Pathways
RUNX2 shows significant involvement in both the Wnt signaling and TGF-beta signaling pathways. Within the Wnt signaling pathway RUNX2 interacts with beta-catenin to facilitate osteoblastogenesis and support bone matrix deposition. In the TGF-beta signaling pathway RUNX2 modulates Smad-dependent transcriptional activity important for extracellular matrix production and bone remodeling. These interactions illustrate RUNX2's central role in mediating bone development and maintenance.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (190)
Recent publications for all applications. Explore the full list and refine your search
Journal of dental sciences 20:2399-2406 PubMed41040543
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 13:1627763 PubMed41041663
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 35:102272 PubMed40994624
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC biology 23:268 PubMed40859304
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 15:1633464 PubMed40837015
2025
Applications
Unspecified application
Species
Unspecified reactive species
Hereditas 162:138 PubMed40696462
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:112395 PubMed40641560
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70703 PubMed40629256
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic translation 53:82-98 PubMed40547193
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 20:571 PubMed40474233
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com